📢Very excited to share this paper with you! The oestrous cycle stage affects mammary tumour sensitivity to chemotherapy published nature . Congratulations to Laura, Colinda Scheele and all the authors for this amazing story. nature.com/articles/s4158…

Amazing summary of LMD-

We're excited about the growing indications for TDXd, particularly for CNS mets. Check out our latest in which we describe the literature, future directions, and show Her2 IHC data from lung cancer brain met pts at The Neuro Rosalind & Morris Goodman Cancer Institute Anna Lazaratos tlcr.amegroups.org/article/view/9…

Check out our latest article in Current Oncology on real-world data for HER2+ and HER2-low BC patients receiving TDXd and its effectiveness in those with brain and leptomeningeal metastases. mdpi.com/1718-7729/32/1…

Machine learning prediction of brain metastasis invasion pattern on brain magnetic resonance imaging scans Out on NeuroOncology Advances buff.ly/4gP7vFf Brain metastasis invasion pattern (BMIP) is a valuable biomarker linked to survival outcomes and therapeutic

Congrats to Kamran Ahmed & team on this important brain mets screening study! The cumulative incidence of brain mets among pts with HR+/HER2-ve mbc whose dz progressed on 1st line ET was quite high (23% @ 6 mo) & comparable to that of pts with HER2+ (24%) and triple neg mbc (25%).

Check out this awesome new study by the spatial biologists Rosalind & Morris Goodman Cancer Institute led by Lysanne Desharnais Mark Sorin and PI @loganawalsh! Few studies provide such detail contrasting the spatial TME of LUSC and LUAD: the two dominant NSCLC histologies! nature.com/articles/s4146…

Study that went under the radar at ASCO. WBRT with hippocampal sparing and memantine versus SRS for 5-20 brain metastases. Same Overall survival, Lower Symptom Burden and Life Interference with SRS, Better KPS with SRS. New standard of care! Congrats Dr. Aizer on this amazing